2seventy Bio Stock Net Asset
| TSVT Stock | USD 4.93 0.33 7.17% |
2Seventy Bio fundamentals help investors to digest information that contributes to 2Seventy Bio's financial success or failures. It also enables traders to predict the movement of 2Seventy Stock. The fundamental analysis module provides a way to measure 2Seventy Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 2Seventy Bio stock.
2Seventy |
2Seventy Bio Company Net Asset Analysis
2Seventy Bio's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current 2Seventy Bio Net Asset | 565.43 M |
Most of 2Seventy Bio's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 2Seventy Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, 2Seventy Bio has a Net Asset of 565.43 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
2Seventy Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 2Seventy Bio's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of 2Seventy Bio could also be used in its relative valuation, which is a method of valuing 2Seventy Bio by comparing valuation metrics of similar companies.2Seventy Bio is currently under evaluation in net asset category among related companies.
2Seventy Fundamentals
| Return On Equity | -0.77 | ||||
| Return On Asset | -0.22 | ||||
| Profit Margin | (2.17) % | ||||
| Operating Margin | (5.60) % | ||||
| Current Valuation | 273.66 M | ||||
| Shares Outstanding | 51.4 M | ||||
| Shares Owned By Insiders | 2.50 % | ||||
| Shares Owned By Institutions | 98.22 % | ||||
| Number Of Shares Shorted | 6.48 M | ||||
| Price To Book | 1.01 X | ||||
| Price To Sales | 2.58 X | ||||
| Revenue | 100.39 M | ||||
| Gross Profit | (183.46 M) | ||||
| EBITDA | (206.42 M) | ||||
| Net Income | (217.57 M) | ||||
| Cash And Equivalents | 357.93 M | ||||
| Cash Per Share | 9.45 X | ||||
| Total Debt | 256.67 M | ||||
| Debt To Equity | 0.73 % | ||||
| Current Ratio | 3.88 X | ||||
| Book Value Per Share | 5.04 X | ||||
| Cash Flow From Operations | (166.86 M) | ||||
| Short Ratio | 4.06 X | ||||
| Earnings Per Share | (4.42) X | ||||
| Target Price | 11.0 | ||||
| Number Of Employees | 274 | ||||
| Beta | 1.85 | ||||
| Market Capitalization | 234.41 M | ||||
| Total Asset | 565.43 M | ||||
| Retained Earnings | (511.22 M) | ||||
| Working Capital | 177.99 M | ||||
| Net Asset | 565.43 M |
About 2Seventy Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 2Seventy Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 2Seventy Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 2Seventy Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether 2Seventy Bio is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if 2Seventy Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about 2seventy Bio Stock. Highlighted below are key reports to facilitate an investment decision about 2seventy Bio Stock:Check out 2Seventy Bio Piotroski F Score and 2Seventy Bio Altman Z Score analysis. For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for 2Seventy Stock analysis
When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |
Is 2Seventy Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 2Seventy Bio. If investors know 2Seventy will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 2Seventy Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of 2Seventy Bio is measured differently than its book value, which is the value of 2Seventy that is recorded on the company's balance sheet. Investors also form their own opinion of 2Seventy Bio's value that differs from its market value or its book value, called intrinsic value, which is 2Seventy Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 2Seventy Bio's market value can be influenced by many factors that don't directly affect 2Seventy Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 2Seventy Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if 2Seventy Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 2Seventy Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.